Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis

NCT04725136 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: FURESTEM-AD inj

Sponsor

Kang Stem Biotech Co., Ltd.